This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ambrose, J. A. Articles by Myler, R. K. Search for Related Content PubMed PubMed Citation Articles by Ambrose, J. A. Articles by Myler, R. K.

Circulation, Vol 90, 69-77, Copyright © 1994 by American Heart Association

ARTICLES

Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial

JA Ambrose, OD Almeida, SK Sharma, SR Torre, JD Marmur, DH Israel, DE Ratner, MB Weiss, CE Hjemdahl-Monsen and RK Myler
Department of Medicine, Mount Sinai Medical Center, New York, NY 10029.

BACKGROUND: Acute closure is increased after angioplasty in unstable angina, and adjunctive intracoronary thrombolytic therapy has been used successfully to increase angiographic success. The role of prophylactic thrombolytic therapy during angioplasty in unstable angina is unknown. METHODS AND RESULTS: Four hundred sixty-nine patients with ischemic rest pain with or without a recent (< 1 month) infarction were randomized in double-blind fashion to intracoronary urokinase or placebo. Randomization was carried out in two sequential phases. In phase I, 257 patients were randomized to 250,000 U of urokinase or placebo given in divided doses at the time of angioplasty. In phase II, 212 patients were randomized to 500,000 U of urokinase or placebo in divided doses. All patients were pretreated with aspirin, and activated clotting times were followed to maintain them at > 300 seconds during angioplasty. Angiographic end points of thrombus after angioplasty were insignificantly decreased by urokinase (30 [13.8%] versus 41 [18.0%] with placebo; P = NS). Acute closure, on the other hand, was increased with urokinase (23 [10.2%] versus 10 [4.3%] with placebo; P < .02). The difference in acute closure between urokinase and placebo was more striking at the higher dose of urokinase (P < .04) than in phase I at the lower urokinase dose (P = NS). Adverse in-hospital clinical end points (ischemia, infarction, or emergency coronary artery bypass surgery) were also increased with urokinase versus placebo (30 [12.9%] versus 15 [6.3%], respectively; P < .02). Angiographic and clinical end points were worse with urokinase in unstable angina without recent infarction than with angioplasty after a recent infarction. CONCLUSIONS: Adjunctive urokinase given prophylactically during angioplasty for ischemic rest angina as administered in this trial is associated with adverse angiographic and clinical events. These detrimental effects may be related to hemorrhagic dissection, lack of intimal sealing, or procoagulant or platelet-activating effects of urokinase.

This article has been cited by other articles:

				J. S. Forrester Toward understanding the evolution of plaque rupture: Correlating vascular pathology with clinical outcomes J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1566 - 1568. [Full Text] [PDF]

				C. L. Grines, P. Serruys, and W. W. O'Neill Fibrinolytic Therapy: Is It A Treatment of the Past? Circulation, May 27, 2003; 107(20): 2538 - 2542. [Full Text] [PDF]

				C. L. Grines, D. R. Westerhausen Jr, L. L. Grines, J. T. Hanlon, T. L. Logemann, M. Niemela, W. D. Weaver, M. Graham, J. Boura, W. W. O'Neill, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1713 - 1719. [Abstract] [Full Text] [PDF]

				H. Luciardi, S. Berman, J. Muntaner, F. De La Serna, and R. Altman Facilitated Thrombolysis: Dethrombosis? Clinical and Applied Thrombosis/Hemostasis, April 1, 2002; 8(2): 133 - 138. [Abstract] [PDF]

				S. H. Wilson, P. B. Berger, V. Mathew, M. R. Bell, K. N. Garratt, C. S. Rihal, J. F. Bresnahan, D. E. Grill, S. Melby, and D. R. Holmes Jr. Immediate and late outcomes after direct stent implantation without balloon predilation J. Am. Coll. Cardiol., March 15, 2000; 35(4): 937 - 943. [Abstract] [Full Text] [PDF]

				Y. Yeghiazarians, J. B. Braunstein, A. Askari, and P. H. Stone Unstable Angina Pectoris N. Engl. J. Med., January 13, 2000; 342(2): 101 - 114. [Full Text] [PDF]

				J. A. Ambrose and G. Dangas Unstable Angina: Current Concepts of Pathogenesis and Treatment Arch Intern Med, January 10, 2000; 160(1): 25 - 37. [Abstract] [Full Text] [PDF]

				P. A. McCullough, W. W. O'Neill, M. Graham, R. J. Stomel, F. Rogers, S. David, A. Farhat, R. Kazlauskaite, M. Al-Zagoum, and C. L. Grines A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial J. Am. Coll. Cardiol., September 1, 1998; 32(3): 596 - 605. [Abstract] [Full Text] [PDF]

				G. F. Gensini, M. Comeglio, and A. Colella Coronary and Peripheral Thrombolysis: Current Status and Recommendations Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 82 - 86. [Abstract] [PDF]

				D. O. Williams, E. Braunwald, B. Thompson, B. L. Sharaf, C. E. Buller, and G. L. Knatterud Results of Percutaneous Transluminal Coronary Angioplasty in Unstable Angina and Non–Q-Wave Myocardial Infarction: Observations from the TIMI IIIB Trial Circulation, December 1, 1996; 94(11): 2749 - 2755. [Abstract] [Full Text]

				L. Oltrona, P. R. Eisenberg, J. M. Lasala, D. J. Sewall, M. E. Shelton, and K. J. Winters Association of Heparin-Resistant Thrombin Activity With Acute Ischemic Complications of Coronary Interventions Circulation, November 1, 1996; 94(9): 2064 - 2071. [Abstract] [Full Text]

				J. A. Bittl Advances in Coronary Angioplasty N. Engl. J. Med., October 24, 1996; 335(17): 1290 - 1302. [Full Text] [PDF]

				L. Grip, C. Hellekant, I. Herzfeld, K. Malmberg, B. Svane, A. Szamosi, M. Velander, and L. Ryden Coronary Angioplasty in Patients with Unstable Angina, with Special Reference to Preceding Treatment with Antithrombin III and Heparin Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 107 - 115. [Abstract] [PDF]

				J. S. Forrester New Standard for Success of Thrombolytic Therapy : An Earnest Proposal Circulation, October 15, 1995; 92(8): 2026 - 2028. [Full Text]